Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study With Axitinib (AG 013736) In Patients With Metastatic Renal Cell Carcinoma After Failure Of One Prior Systemic First-Line Therapy

NCT01473043 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01473043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01473043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study With Axitinib (AG 013736) In Patients With Metastatic Renal Cell Carcinoma After Failure Of One Prior Systemic First-Line Therapy
Lead sponsor
Pfizer
Phase
Expanded access
Overall status
No longer available
Start date
March 31, 2012
Completion date
March 31, 2014
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma